A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy.
Kodama A, Watanabe H, Tanaka R, Tanaka H, Chuang VT, Miyamoto Y, Wu Q, Endo M, Hamasaki K, Ishima Y, Fukagawa M, Otagiri M, Maruyama T.
Kodama A, et al.
Kidney Int. 2013 Mar;83(3):446-54. doi: 10.1038/ki.2012.429. Epub 2013 Jan 2.
Kidney Int. 2013.
PMID: 23283135
Free article.